P36R (p.Pro36Arg) variant of TP53 (Cellular tumor antigen p53)
P36R (p.Pro36Arg) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from EBI and UniProt describe it as benign in the context of in a sporadic cancer. The available variant effect predictions contribute to a CATVariant prioritization score of 0.38 / 1. The record also includes experimental measurements and structural context.
P36R (p.Pro36Arg) variant details
- p.Pro36Arg
- ExAC rs587781866
- TOPMed rs587781866
- gnomAD rs587781866
- Benign
- in a sporadic cancer
- Missense
- Variant Prioritization Score for Impact Estimate 0.381
- ESM-1b 0.21
- AlphaMissense 0.10
- EBI: Benign (in a sporadic cancer)
- UniProt: Benign (in a sporadic cancer)
- Structural context available
- p53 variant effect measured by cell growth: score -3.65